方法对比
并排查看您选择的方法;存在差异的行会高亮显示。
| 药代动力学房室模型× | 生物等效性分析(双单侧检验法)× | |
|---|---|---|
| 领域 | 定量药理学 | 定量药理学 |
| 方法族≠ | Regression model | Hypothesis test |
| 起源年份≠ | 1982 | 1987 |
| 提出者≠ | Gibaldi & Perrier | Donald J. Schuirmann |
| 类型≠ | Deterministic ODE-based pharmacokinetic model | Parametric equivalence test |
| 开创性文献≠ | Gibaldi, M., & Perrier, D. (1982). Pharmacokinetics (2nd ed.). Marcel Dekker. ISBN: 978-0-8247-1042-2 | Schuirmann, D. J. (1987). A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. Journal of Pharmacokinetics and Biopharmaceutics, 15(6), 657–680. DOI ↗ |
| 别名 | Mammillary Compartment Model, Multi-Compartment PK Model, Compartmental Analysis, Farmakokinetik Kompartman Modeli | TOST Procedure, Average Bioequivalence, BE Analysis, Biyoeşdeğerlik Analizi |
| 相关≠ | 3 | 2 |
| 摘要≠ | The pharmacokinetic compartment model represents the body as one or more hypothetical compartments interconnected by first-order rate processes, describing how a drug is absorbed, distributed, and eliminated over time. Systematized by Gibaldi and Perrier in 1982, these models use ordinary differential equations to characterize plasma concentration-time profiles. They are the cornerstone of drug development, dosage regimen design, and regulatory submission pharmacokinetic analyses. | Bioequivalence Analysis is a regulatory-grade statistical framework used to determine whether a test drug formulation (generic or reformulated) delivers the active ingredient to the systemic circulation at a rate and extent comparable to a reference product. Introduced by Donald J. Schuirmann in 1987, the method operationalizes equivalence through the Two One-Sided Tests (TOST) procedure, replacing the ambiguous absence-of-difference paradigm with an explicit equivalence margin evaluated on log-transformed pharmacokinetic endpoints such as AUC and C_max. |
| ScholarGate数据集 ↗ |
|
|